Imatinib Spirig HC 100 mg
Imatinib Spirig HC 100 mg is a medicine authorised by Swissmedic under authorisation number 69955. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 April 2025 and the authorisation is limited until 15 April 2030. ATC code L01EA01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69955 |
|---|---|
| Name | Imatinib Spirig HC 100 mg |
| Full name | Imatinib Spirig HC 100 mg, Filmtabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EA01 |
| First authorisation | 16 April 2025 |
| Authorisation validity | 15 April 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Imatinib Spirig HC 100 mg, Filmtabletten | A | 16 April 2025 |
| 2 | Imatinib Spirig HC 400 mg, Filmtabletten | A | 16 April 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 60 | Tablette(n) | L01EA01 | 07.16.1. | A |
| 2 | 30 | Tablette(n) | L01EA01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Imatinib Spirig HC 100 mg authorised in Switzerland?
Yes. Imatinib Spirig HC 100 mg is authorised by Swissmedic under authorisation number 69955, data as of 01 September 2026. The authorisation is limited until 15 April 2030.
Which dispensing category does Imatinib Spirig HC 100 mg have?
Imatinib Spirig HC 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Imatinib Spirig HC 100 mg?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.